(Q38332045)

2 September 2017

title

Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes (English)

1 reference

2 September 2017

Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (αl-3)-galactose epitopes (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB02939.X

8 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB02939.X

8 November 2022

author name string

A. Gabrielli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721011

8 November 2022

M. Candela

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721011

8 November 2022

A. M. Ricciatti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721011

8 November 2022

M. L. Caniglia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721011

8 November 2022

J. Wieslander

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721011

8 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1721011

8 November 2022

publication date

1 December 1991

1 reference

full work available at URL

2 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2249.1991.tb02939.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB02939.X

https://academic.oup.com/cei/article-pdf/86/3/367/42213775/j.1365-2249.1991.tb02939.x.pdf

8 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB02939.X

Clinical and Experimental Immunology

8 November 2022

published in

1 reference

2 September 2017

volume

86

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

367-373

1 reference

Collagen in the cellular and fibrotic stages of scleroderma

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Ultrastructure of Cutaneous Cellular Infiltrates in Scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Structure and distribution of N-linked oligosaccharide chains on various domains of mouse tumour laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

High antibody levels against mouse laminin with specificity for galactosyl-(alpha 1-3)galactose in patients with inner ear diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

The immunochemistry of Salmonella chemotype VI O-antigens. The structure of oligosaccharides from Salmonella group U (o 43) lipopolysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Antibodies to laminin in Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

22 Antibodies to collagens and procollagens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

Affinity purification of antibodies using oligosaccharide-phenethylamine derivaties coupled to Sepharose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

PROGRESSIVE SYSTEMIC SCLEROSIS: AUTOIMMUNE ARTERIOPATHY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1991.TB02939.X

A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon

21 January 2018

1 reference

12 December 2020

Possible role of human natural anti-Gal antibodies in the natural antitumor defense system

1 reference

12 December 2020

Cellular immunity to collagen and laminin in scleroderma

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis

1 reference

12 December 2020

Antibodies to collagen in scleroderma

1 reference

12 December 2020

Antibodies to laminin in American cutaneous leishmaniasis

1 reference

12 December 2020

Laminin–a glycoprotein from basement membranes

1 reference

12 December 2020

Immunopathology of the renal vascular lesion of progressive systemic sclerosis (scleroderma)

1 reference

12 December 2020

Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes

1 reference

12 December 2020

The γG subclass of antinuclear and antinucleic acid antibodies

1 reference

12 December 2020

Antibodies against galactosyl (alpha 1----3) galactose in connective tissue diseases

1 reference

12 December 2020

Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora

1 reference

12 December 2020

Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania

1 reference

12 December 2020

Antibodies to basement membrane proteins nidogen and laminin in sera from streptococcal-related diseases and juvenile rheumatoid arthritis patients

1 reference

12 December 2020

Antibodies to basement membrane protein nidogen in Chagas' disease and American cutaneous leishmaniasis

1 reference

12 December 2020

Serological activity against galactosyl-alpha(1-3)galactose in sera from patients with several kinetoplastida infections

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB02939.X

The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity

8 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB02939.X

8 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

2 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1721011

8 November 2022

1 reference